Eli Lilly Stock Falls. Novo Extends Lead in Weight-Loss Drug Race - Yahoo Finance

Eli Lilly Stock Falls. Novo Extends Lead in Weight-Loss Drug Race - Yahoo Finance
Business

Listen to this article

0%

This article first appeared on GuruFocus. Eli Lilly (NYSE:LLY) shares fell about 4% on Friday after data indicated its obesity drug prescriptions were trailing those of rival Novo Nordisk. Eli Lill… [+859 chars]

Leave A Comment

Comments are moderated and may take time to appear.

Comments

No comments yet. Be the first to comment!

Stay Connected